About US
Contact us
-
Shadowed by nearly $30B in debt, Valeant's $50M guidance raise looks pretty paltry, analyst saysFaced with a crippling pile of debt, Valeant on Tuesday slightly increased its 2017 earnings guidance, one small positive development as it works to rebound from its noted downfall. The Canadian drug2017/5/23
-
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C medsAs if Johnson & Johnson didn’t have enough legal woes already, with the mounting number of cases claiming alinkbetween its talcum powder and ovarian cancer, the pharma giant now faces a fresh roun2017/5/23
-
Louisiana wants HHS head Price to sidestep Gilead hepatitis C patents: reportUnder great pressure to make an M&A move and grappling with crashing hepatitis C sales, Gilead Sciences could soon find itself facing another challenge, this time from the U.S. government. Loui2017/5/22
-
J&J loses latest talc verdict and ordered to pay $110MIn what has turned out to be a mixed week in court for Johnson & Johnson, the drugmakertook a took a damaging hit late Thursday as a St. Louis jury awarded the largest verdict to date in the ongoi2017/5/22
-
Pfizer faces renewed bid for Xalkori royalties as appeals panel revives NYU lawsuitPfizer thought it had escaped the prospect of paying tens of millions in royalties on its lung cancer drug Xalkori. But an appeals court resurrected New York University's claims for a share of the dru2017/5/19
-
J&J, Bayer prevail in bellwether Xarelto trialThe first trial over blockbuster Xarelto’s bleeding risks has swung in Bayer and Johnson & Johnson’s favor as a New Orleans jury decided on Wednesday the Big Pharma companies didn’t fail to warn a2017/5/19
-
Feds descend on Perrigo offices with search warrantsA number of generics makers have said that they have been asked by federal authorities to turn over info about drug pricing in a probe that has already led to charges against the execs of one company.2017/5/18
-
Eli Lilly's insulin pricing scrutiny intensifies with newly disclosed state AG probesAlready under fire for its insulin pricing, Eli Lilly faces a pair of new investigations by state attorneys general. In a securities filing, Lillydisclosedthat the Washington state attorney general i2017/5/18
-
Novo Nordisk reaches whistleblower settlement in 'white-coat' sales scheme lawsuitNovo Nordisk has moved to settle a whistleblower lawsuit alleging the company ran a “white-coat marketing scheme” to pump up sales of NovoLog, Victoza and Levemir. According to thesuit(PDF)—recentl2017/5/17
-
As Supreme Court steps into tangled biosimilars law, IP experts weigh inU.S. Supreme Court justices took their shot at picking apart the knotty Biologics Price Competition and Innovation Act on Wednesday, questioningAmgen and Sandoz attorneys about the “patent dance” lead2017/5/17